Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04191382
Title Phase 2 Window Study of SAR439859 Versus Letrozole in ER+, HER2- Pre-operative Post-menopausal Primary Breast Cancer (AMEERA-4)
Recruitment Terminated
Gender female
Phase Phase II
Variant Requirements No
Sponsors Sanofi
Indications

Her2-receptor negative breast cancer

Therapies

Letrozole

Amcenestrant

Age Groups: senior | adult
Covered Countries USA | ITA | FRA | ESP | BEL

Facility Status City State Zip Country Details
Investigational Site Number 8400014 Tucson Arizona 85724 United States Details
Investigational Site Number 8400010 Los Angeles California 90095 United States Details
Investigational Site Number 8400018 Fort Wayne Indiana 46804 United States Details
Investigational Site Number 8400005 Lincoln Nebraska 68506 United States Details
Investigational Site Number 8400016 Winston-Salem North Carolina 27157 United States Details
Investigational Site Number 8400012 Tacoma Washington 98405 United States Details
Investigational Site Number 0560001 Leuven 3000 Belgium Details
Investigational Site Number 0560002 Namur 5000 Belgium Details
Investigational Site Number 2500001 Nantes 44093 France Details
Investigational Site Number 2500004 Paris 75010 France Details
Investigational Site Number 2500002 Saint Cloud 92210 France Details
Investigational Site Number 2500003 Toulouse Cedex 9 31059 France Details
Investigational Site Number 3800004 Meldola 47014 Italy Details
Investigational Site Number 3800002 Milano 20132 Italy Details
Investigational Site Number 3800001 Milano 20141 Italy Details
Investigational Site Number 3920002 Osaka-Shi Japan Details
Investigational Site Number 3920003 Sapporo-Shi Japan Details
Investigational Site Number 3920001 Yokohama-Shi Japan Details
Investigational Site Number 8400007 Hato Rey 00917 Puerto Rico Details
Investigational Site Number 6430006 Moscow 117186 Russian Federation Details
Investigational Site Number 6430004 Moscow 119991 Russian Federation Details
Investigational Site Number 6430002 Saint -Petersburg 197758 Russian Federation Details
Investigational Site Number 6430003 Saint-Petersburg 194156 Russian Federation Details
Investigational Site Number 6430007 St.Petersburg 195271 Russian Federation Details
Investigational Site Number 7240005 Barcelona 08003 Spain Details
Investigational Site Number 7240003 Córdoba 14004 Spain Details
Investigational Site Number 7240001 Madrid 28041 Spain Details
Investigational Site Number 7240002 Valencia / Valencia 46010 Spain Details
Investigational Site Number 8040004 Kharkiv 61166 Ukraine Details
Investigational Site Number 8040001 Uzhgorod 88000 Ukraine Details
Investigational Site Number 8040002 Vinnytsia 21029 Ukraine Details
Investigational Site Number 8040005 Zaporizhzhya 69040 Ukraine Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field